Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.02 per share, down from $4.20 per share in the year-ago period. Vertex Pharmaceuticals projects quarterly ...

U.S. stock futures rose on Monday after Friday’s sharp fall as investors digested the tariff updates and earnings reports.

In the meantime, the gap, or spread, between LME and COMEX futures prices has widened to $740 a tonne, its highest in around ...

To avoid a tug-of-war between scientific rigour and operational efficiency, we must focus on the user and data journeys of ...

Invest in Capital Group Growth ETF (CGGR) for high-growth stocks and solid portfolio management to capitalize on market ...

A new telescope could launch as early as late February. SPHEREx will look into deep space and also search for organic molecules.

Setting aside a rather brief hiccup mid-quarter, the bull market in global equities continued in force during Q4 2024. Click here to read the full commentary.

Scammers Are Zeroing In on the Super Bowl: Here's How to Keep Your Info and Money Safe ...

Google has officially launched access to its most advanced AI model yet, the Gemini 2.0 Pro experimental model.